Barriers to Medication Adherence - Addressing Cost and Patient Understanding

Thursday, October 13, 2022, 12:00 PM - 1:00 PM, Online


AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Non-Physician Attendance (1.00 hours)

Barriers to Medication Adherence: Addressing Cost and Patient Understanding. In our world of value-based contracts, medication adherence can play a major role in quality scores due to patient outcomes. Yet, most physicians have very little visibility into patient adherence regarding recommended medications once the visit is completed. This webinar aims to provide an analysis of the issue of medication affordability and the clinical implications for patient adherence to treatment recommendations. Expert speakers will give insights into the key components of medication management and provide tools for how physicians can help their patients to best navigate this common process. A comprehensive overview of this theme will be discussed by keynote speaker, Dr. Rox Gatia, PharmD – Vice President of Pharmacy for Henry Ford Health. Dr. Gatia will delve into this topic from a system-level perspective, and will discuss the important interactions between physicians, patients, payers, and providers that contribute to medication affordability and adherence. Participants will have the opportunity to ask questions of Dr. Gatia following his brief presentation. Next, HFPN President and CEO Dr. Bruce Muma will moderate a panel discussion with Dr. Gatia alongside Dr. Sandra Nowak, PharmD, manager of the Henry Ford Health Medication Therapy Management team and Sarah Spannbauer, healthcare strategy analyst for General Motors (GM). Dr. Nowak will provide her perspective on the tools used to help patients manage their prescriptions and address patient questions related to medicines or supplements, in addition to discussing the significance of pharmacist-patient interactions. Sarah will discuss how GM, as payer in a direct-to-employer contract, educates employees/enrollees on medication related concerns.

1. Increase understanding on the scope of the issue of medication affordability
2. Increase understanding of the implications of affordability on patient adherence
3. Gain knowledge of tools/resources available to assist patients with their medication management needs
4. Gain transparency into the entire process of medication management, considering the interactions between physicians, patients, pharmacists, payers, and others
5. Knowledge on how Henry Ford Health has approached this issue through programs and resources for patients
6. See the perspective of a payer/employer on how medication adherence is approached with beneficiaries

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: Henry Ford Health designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

The Henry Ford Health Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, October 13, 2022